SlideShare a Scribd company logo
COVID-19
COVID-19 What Is It?
• Virus
• Highly contagious
• 3.5 times more deadly than the seasonal flu virus
• Has already developed numerous variants throughout the world,
which allow it to spread quicker than the original sars-cov-2 virus
(Covid-19). Currently, not all variants have arrived in Canada and not
all variants are listed below.
• B.1.1.7 UK variant
• B.1.351 South African variant
• B.1.525 Nigerian variant
• Cal.20C Californian variant
• P.1 Brazilian variant
Why is This so concerning?
• With the variants spreading quicker;
• It can put a strain on the healthcare resources (Covid-19 test sites,
doctor’s offices, hospitals, labs)
• It can lead to more hospitalizations
• Potentially lead to more deaths
• Existing health issues continue to compound, as surgeries would be
cancelled and people will continue to avoid obtaining
healthcare for routine preventative measures
• It can put a strain on community resources (ex: taxi services and
ambulance services take longer for turn around due to disinfectant
processes, increased costs)
How Does it Spread?
• Through respiratory droplets
• Close prolonged contact (defined as 15 minutes within a 24
timeframe)
• Touching an infected area and then touching your eyes, nose or
mouth
• **It can survive on some surfaces outside the human body for up to 7
• days, but specifically;
• Up to 3 hours as an aerosol
• Up to 72 hours on plastic and stainless steel
• Up to 4 hours on copper
• Up to 24 hours on cardboard
• 5 days on glass
• 4 days on wood
So, What Happens When You
Get EXPOSED?
• The virus gets in your body through your eyes, nose, or mouth
• It attaches to the ACE2 receptors in the body, which is a protein that
lines our organs (lungs, heart, blood vessels, kidneys, liver, GI tract)
• Once it attaches to these proteins, it causes inflammation
• This can overwhelm your immune system
• Under certain conditions (increased risk factors discussed later), there
is an increased risk of experiencing severe symptoms of the COVID-19,
or even death
Different Categories of Infection
Once you are infected you are either:
Asymptomatic
(no symptoms for the
duration)
Pre-symptomatic
(Currently exhibiting no symptoms
but will eventually develop
symptoms)
Symptomatic
(Currently exhibiting symptoms)
The World Health Organization (WHO) believes that once you are infected, you have the
potential to infect others, regardless of the degree of symptoms you are
exhibiting.
In fact, the WHO also believes that you are more likely to infect others around the time
you are experiencing the onset of symptoms
COVID-19 Symptoms
• Watch for symptoms.
• Symptoms can vary from person to person and in different age
groups.
• Symptoms may take up to 14 days to appear after exposure to COVID-
19.
• The severity of COVID-19 symptoms can range from mild to severe,
and in some cases, can lead to death.
• Current information suggests most people don't experience severe
illness or need to be hospitalized.
EPIDEMIOLOGY
• Since the initial report from China, the disease spread rapidly, and the number
of cases increased exponentially.
• On January 11, the first case was reported outside mainland China in Thailand,
7 and within months, the disease spread to all the continents except
Antarctica. India reported its first case of COVID-19 on January 30, 2020.
• This rose to three cases by February 3, 2020. No further cases were reported
in February 2020.
• However, by mid-March, the number of infected cases started to increase, and
many cases were reported from all over India.
• The first COVID-19 related death in India was reported on March 12, 2020. By
the second week of April, the disease spread to all states in India except
Sikkim.
• At the time of writing this manuscript, there have been 2,170,265 cases and
135,163 deaths globally and 15,712 cases and 507 deaths in India.
PERSON
PLACE
PLACE
PLACE
TIME
COMMON SYMPTOMS
Sore throat
Cough
(new or
worsening)
Shortness
of breath
Fever
(chills, sweats)
Headache
YOU should get tested For COVID-19
• If you have symptoms of Covid-19
• If Public Health determines you are a close or moderate contact of a confirmed
case of Covid-19
• If you were at a potential exposure site (see http://www.nshealth.ca/covid-
exposures?title=&field_covid_exposure_zone_value=All&order=changed&sort=d
esc for updated list and directions)
• If you have travelled and arrived in Canada recently
• If you don’t have symptoms, it is recommended that you get routine testing to
ensure you are not an asymptomatic carrier of the virus
• If you are experiencing any other symptoms that concern you
• **If you are asked to isolate by 811, please inform your immediate supervisor and
depending on the severity of your symptoms, discuss work options at that time
Recovery
• Most people with COVID-19 recover or feel better within
two weeks.
• Severe cases can take longer than 6 weeks and may or
may not cause permanent damage to your organs.
• There is currently insufficient research, but some
individuals are reporting lingering symptoms after COVID-
19 infection (called long-haulers).
PRIMARY PREVENTION
• No compromise can be made for adherence to the main
pillars of primary prevention including physical distancing,
wearing a mask, keeping rooms well ventilated, avoiding
crowds, cleaning the hands, and coughing into a bent
elbow or tissue.
secondary prevention
• The secondary prevention measures of Coronavirus disease 2019 (COVID-
19)encompasses measures to make sure that an infected individual does not transfer
the disease to others.
• Infection Control : WHO recommends home care for patients with suspected COVID-
19 who present with mild symptoms.
• It is highly recommended for people with suspected or affirmed COVID-19 (including
those anticipating test results) should remain at home and attempt to isolate
themselves from other members and animals in the family unit.
• World Health Organization (WHO) has recommended wearing a medical mask if
family members are in the same room with the COVID-19 patient to prevent the
spread of the virus. Whereas, according to the United States Centers for Disease
Control and Prevention (CDC), a cloth face Cover can be acceptable for caregivers at
home and has considered the use of a medical mask for healthcare workers.
• It is highly recommended for COVID-19.patients to use a separate bedroom and
bathroom to prevent the spread of infection to family members. To avoid sharing
rooms and if sharing space in a home is unavoidable, keeping a six feet (two meters)
distance is extremely emphasized.
secondary prevention Cont.
• Care providers should perform hand hygiene after any form of contact with patients
or their immediate environment. In a process of providing care to the patient, the
caregiver should wear gloves while touching the patient's blood, stool, or body fluids,
such as saliva, sputum, nasal mucus, vomit, and urine.
• Certain things should not be shared with COVID-19 patients such as dishes, drinking
glasses, cups, eating utensils, towels, bedding, and thermometers. After theCOVID-19
patients use these things, they should be properly disinfected.
• COVID-19 patients who require nebulizer treatment and patients with sleep apnea
who use continuous positive airway pressure (CPAP) machine should avoid using
them in shared spaces where there is a risk of aerosol transmission to family
members.
• Symptomatic Treatment:• Symptomatic treatment of mild COVID-19 includes
antipyretics and analgesics for fever, myalgias, and headaches.• Lying on a prone
position has shown a symptomatic . improvement for patients with cough or
dyspnea.
• Anti-Viral Therapy for COVID-19:
Tertiary prevention
• Tertiary prevention strategies seek to treat and
rehabilitate those with the clinical disease,
toward reducing sequelae or complications and
improving quality of life within a holistic or
biopsychosocial framework.
CREDITS: This presentation template was created by Slidesgo,
including icons by Flaticon, and infographics & images by Freepik
Thanks!
Do you have any questions?

More Related Content

What's hot

Dengue epidemiology
Dengue epidemiologyDengue epidemiology
Dengue epidemiology
Seema Verma
 
Understanding Monkeypox
Understanding MonkeypoxUnderstanding Monkeypox
Understanding Monkeypox
CNS www.citizen-news.org
 
Small pox and chicken pox
Small pox and chicken poxSmall pox and chicken pox
Small pox and chicken pox
Rizwan S A
 
Novel corona virus (COVID-19) its cause, symptoms and treatment
Novel corona virus (COVID-19) its cause, symptoms and treatmentNovel corona virus (COVID-19) its cause, symptoms and treatment
Novel corona virus (COVID-19) its cause, symptoms and treatment
Medical Knowledge
 
Epidemiology of communicable diseases
Epidemiology of communicable diseasesEpidemiology of communicable diseases
Epidemiology of communicable diseases
Dalia El-Shafei
 
COVID-19 | Corona Virus
COVID-19 | Corona VirusCOVID-19 | Corona Virus
COVID-19 | Corona Virus
Maneesha M Joseph
 
National Vector Borne Disease Control Programme (NVBDCP)
 National Vector Borne Disease Control Programme (NVBDCP) National Vector Borne Disease Control Programme (NVBDCP)
National Vector Borne Disease Control Programme (NVBDCP)
Kailash Nagar
 
EPIDEMIOLOGY OF FILARIASIS
EPIDEMIOLOGY OF FILARIASISEPIDEMIOLOGY OF FILARIASIS
EPIDEMIOLOGY OF FILARIASIS
MAHESWARI JAIKUMAR
 
Covid 19
Covid 19Covid 19
Covid 19
AvinandanPal2
 
Malaria
MalariaMalaria
Malaria
Swati Singh
 
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Arun Singh
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
Dr Lipilekha Patnaik
 
Chikungunya virus
Chikungunya virus  Chikungunya virus
Chikungunya virus
Amjad Afridi
 
CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19
Dr.Hashim Syed Ali (Dr.Foster)
 
Emerging & re emerging infections
Emerging & re emerging infectionsEmerging & re emerging infections
Emerging & re emerging infections
swati shikha
 
Epidemiology of measles
Epidemiology of measlesEpidemiology of measles
Epidemiology of measles
mayfair one
 
Dengue prevention & control
Dengue prevention & controlDengue prevention & control
Dengue prevention & control
Geetha Mani
 
EPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIAEPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIA
MAHESWARI JAIKUMAR
 
Job responsibility of medical officer in primary health
Job responsibility of medical officer in primary healthJob responsibility of medical officer in primary health
Job responsibility of medical officer in primary health
farranajwa
 
Vector borne diseases
Vector borne diseasesVector borne diseases
Vector borne diseases
INAAMUL HAQ
 

What's hot (20)

Dengue epidemiology
Dengue epidemiologyDengue epidemiology
Dengue epidemiology
 
Understanding Monkeypox
Understanding MonkeypoxUnderstanding Monkeypox
Understanding Monkeypox
 
Small pox and chicken pox
Small pox and chicken poxSmall pox and chicken pox
Small pox and chicken pox
 
Novel corona virus (COVID-19) its cause, symptoms and treatment
Novel corona virus (COVID-19) its cause, symptoms and treatmentNovel corona virus (COVID-19) its cause, symptoms and treatment
Novel corona virus (COVID-19) its cause, symptoms and treatment
 
Epidemiology of communicable diseases
Epidemiology of communicable diseasesEpidemiology of communicable diseases
Epidemiology of communicable diseases
 
COVID-19 | Corona Virus
COVID-19 | Corona VirusCOVID-19 | Corona Virus
COVID-19 | Corona Virus
 
National Vector Borne Disease Control Programme (NVBDCP)
 National Vector Borne Disease Control Programme (NVBDCP) National Vector Borne Disease Control Programme (NVBDCP)
National Vector Borne Disease Control Programme (NVBDCP)
 
EPIDEMIOLOGY OF FILARIASIS
EPIDEMIOLOGY OF FILARIASISEPIDEMIOLOGY OF FILARIASIS
EPIDEMIOLOGY OF FILARIASIS
 
Covid 19
Covid 19Covid 19
Covid 19
 
Malaria
MalariaMalaria
Malaria
 
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
 
Chikungunya virus
Chikungunya virus  Chikungunya virus
Chikungunya virus
 
CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19CORONA VIRUS - COVID 19
CORONA VIRUS - COVID 19
 
Emerging & re emerging infections
Emerging & re emerging infectionsEmerging & re emerging infections
Emerging & re emerging infections
 
Epidemiology of measles
Epidemiology of measlesEpidemiology of measles
Epidemiology of measles
 
Dengue prevention & control
Dengue prevention & controlDengue prevention & control
Dengue prevention & control
 
EPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIAEPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIA
 
Job responsibility of medical officer in primary health
Job responsibility of medical officer in primary healthJob responsibility of medical officer in primary health
Job responsibility of medical officer in primary health
 
Vector borne diseases
Vector borne diseasesVector borne diseases
Vector borne diseases
 

Similar to Covid 19 epidemiology

COVID-19 ORIENTATION Jan 2022-2.pptx
COVID-19 ORIENTATION Jan 2022-2.pptxCOVID-19 ORIENTATION Jan 2022-2.pptx
COVID-19 ORIENTATION Jan 2022-2.pptx
PreetiSaini756391
 
CORONA VIRUS & it’s effect on daily life
CORONA VIRUS & it’s effect on  daily lifeCORONA VIRUS & it’s effect on  daily life
CORONA VIRUS & it’s effect on daily life
Danao Maibam
 
Detail Question and Answers on Covid-19 for Public
Detail Question and Answers on Covid-19 for PublicDetail Question and Answers on Covid-19 for Public
Detail Question and Answers on Covid-19 for Public
Shivam Parmar
 
#Covid19: Information guide for general Public.
#Covid19: Information guide for general Public.#Covid19: Information guide for general Public.
#Covid19: Information guide for general Public.
MADHUR VERMA
 
How to protect your self from coronavirus
How to protect your self from coronavirusHow to protect your self from coronavirus
How to protect your self from coronavirus
Univ. of Tripoli
 
Covid 19
Covid 19 Covid 19
Covid 19
ishikachoudhary6
 
COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )
VivekKumar3314
 
Corona
CoronaCorona
Covid 19 (corona virus)
Covid 19 (corona virus)Covid 19 (corona virus)
Covid 19 (corona virus)
Amar joseph
 
Covid -19
Covid -19Covid -19
Covid -19
MrSanny
 
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار
 
Coronavirus covid19-nursing-professional-post-acute-care-text-version
Coronavirus covid19-nursing-professional-post-acute-care-text-versionCoronavirus covid19-nursing-professional-post-acute-care-text-version
Coronavirus covid19-nursing-professional-post-acute-care-text-version
د حاتم البيطار
 
Covid19 course د حاتم البيطار
Covid19 course  د حاتم البيطارCovid19 course  د حاتم البيطار
Covid19 course د حاتم البيطار
د حاتم البيطار
 
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
Shivam Parmar
 
Nitin Yadav pptx.pptxvtctctcyctctctxtftftftf
Nitin Yadav pptx.pptxvtctctcyctctctxtftftftfNitin Yadav pptx.pptxvtctctcyctctctxtftftftf
Nitin Yadav pptx.pptxvtctctcyctctctxtftftftf
MrMedicine
 
2019 ncovarifa-200126133128
2019 ncovarifa-2001261331282019 ncovarifa-200126133128
2019 ncovarifa-200126133128
Dr.Arifa Akram
 
Covid 19
Covid 19Covid 19
Covid 19
YousraSafdar
 
WHO COVID-19 Guidelines
WHO COVID-19 GuidelinesWHO COVID-19 Guidelines
WHO COVID-19 Guidelines
Henrique Diez Botelho
 
COVID-19- The Pandemic Outbreak
COVID-19- The Pandemic OutbreakCOVID-19- The Pandemic Outbreak
COVID-19- The Pandemic Outbreak
SonikaPawar
 
CORONAVIRUS DISEASE (COVID-19)
CORONAVIRUS DISEASE (COVID-19)CORONAVIRUS DISEASE (COVID-19)
CORONAVIRUS DISEASE (COVID-19)
DrHimanshuKhatri
 

Similar to Covid 19 epidemiology (20)

COVID-19 ORIENTATION Jan 2022-2.pptx
COVID-19 ORIENTATION Jan 2022-2.pptxCOVID-19 ORIENTATION Jan 2022-2.pptx
COVID-19 ORIENTATION Jan 2022-2.pptx
 
CORONA VIRUS & it’s effect on daily life
CORONA VIRUS & it’s effect on  daily lifeCORONA VIRUS & it’s effect on  daily life
CORONA VIRUS & it’s effect on daily life
 
Detail Question and Answers on Covid-19 for Public
Detail Question and Answers on Covid-19 for PublicDetail Question and Answers on Covid-19 for Public
Detail Question and Answers on Covid-19 for Public
 
#Covid19: Information guide for general Public.
#Covid19: Information guide for general Public.#Covid19: Information guide for general Public.
#Covid19: Information guide for general Public.
 
How to protect your self from coronavirus
How to protect your self from coronavirusHow to protect your self from coronavirus
How to protect your self from coronavirus
 
Covid 19
Covid 19 Covid 19
Covid 19
 
COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )
 
Corona
CoronaCorona
Corona
 
Covid 19 (corona virus)
Covid 19 (corona virus)Covid 19 (corona virus)
Covid 19 (corona virus)
 
Covid -19
Covid -19Covid -19
Covid -19
 
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
 
Coronavirus covid19-nursing-professional-post-acute-care-text-version
Coronavirus covid19-nursing-professional-post-acute-care-text-versionCoronavirus covid19-nursing-professional-post-acute-care-text-version
Coronavirus covid19-nursing-professional-post-acute-care-text-version
 
Covid19 course د حاتم البيطار
Covid19 course  د حاتم البيطارCovid19 course  د حاتم البيطار
Covid19 course د حاتم البيطار
 
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
 
Nitin Yadav pptx.pptxvtctctcyctctctxtftftftf
Nitin Yadav pptx.pptxvtctctcyctctctxtftftftfNitin Yadav pptx.pptxvtctctcyctctctxtftftftf
Nitin Yadav pptx.pptxvtctctcyctctctxtftftftf
 
2019 ncovarifa-200126133128
2019 ncovarifa-2001261331282019 ncovarifa-200126133128
2019 ncovarifa-200126133128
 
Covid 19
Covid 19Covid 19
Covid 19
 
WHO COVID-19 Guidelines
WHO COVID-19 GuidelinesWHO COVID-19 Guidelines
WHO COVID-19 Guidelines
 
COVID-19- The Pandemic Outbreak
COVID-19- The Pandemic OutbreakCOVID-19- The Pandemic Outbreak
COVID-19- The Pandemic Outbreak
 
CORONAVIRUS DISEASE (COVID-19)
CORONAVIRUS DISEASE (COVID-19)CORONAVIRUS DISEASE (COVID-19)
CORONAVIRUS DISEASE (COVID-19)
 

More from ABHISHEK

Cells of the immune system
Cells of the immune systemCells of the immune system
Cells of the immune system
ABHISHEK
 
First line of defense ( barrier mechanisms)
First line of defense ( barrier mechanisms)First line of defense ( barrier mechanisms)
First line of defense ( barrier mechanisms)
ABHISHEK
 
Second line of defense
Second line of defenseSecond line of defense
Second line of defense
ABHISHEK
 
Vaccination
Vaccination Vaccination
Vaccination
ABHISHEK
 
Tuberculosis. epidemiology person, place, time graph
Tuberculosis. epidemiology person, place, time graphTuberculosis. epidemiology person, place, time graph
Tuberculosis. epidemiology person, place, time graph
ABHISHEK
 
Trauma epidemiology person, place, time graph
Trauma epidemiology person, place, time graphTrauma epidemiology person, place, time graph
Trauma epidemiology person, place, time graph
ABHISHEK
 
Stroke epidemiology person, place, time graph
Stroke epidemiology person, place, time graphStroke epidemiology person, place, time graph
Stroke epidemiology person, place, time graph
ABHISHEK
 
Sexually transmitted diseases (st ds) epidemiology person, place, time graph
Sexually transmitted diseases (st ds) epidemiology person, place, time graphSexually transmitted diseases (st ds) epidemiology person, place, time graph
Sexually transmitted diseases (st ds) epidemiology person, place, time graph
ABHISHEK
 
Pneumonia.epidemiology person, place, time graph
Pneumonia.epidemiology  person, place, time graphPneumonia.epidemiology  person, place, time graph
Pneumonia.epidemiology person, place, time graph
ABHISHEK
 
Malaria disease epidemiology person, place, time graph
Malaria disease epidemiology person, place, time graphMalaria disease epidemiology person, place, time graph
Malaria disease epidemiology person, place, time graph
ABHISHEK
 
Hypertension.epidemiology person, place, time graph
Hypertension.epidemiology person, place, time graphHypertension.epidemiology person, place, time graph
Hypertension.epidemiology person, place, time graph
ABHISHEK
 
Hiv disease epidemiology person, place, time graph
Hiv disease epidemiology person, place, time graphHiv disease epidemiology person, place, time graph
Hiv disease epidemiology person, place, time graph
ABHISHEK
 
Hepatitis epidemiology person, place, time graph
Hepatitis epidemiology person, place, time graphHepatitis epidemiology person, place, time graph
Hepatitis epidemiology person, place, time graph
ABHISHEK
 
Hepatitis – b ,epidemiology person, place, time graph
Hepatitis – b ,epidemiology person, place, time graphHepatitis – b ,epidemiology person, place, time graph
Hepatitis – b ,epidemiology person, place, time graph
ABHISHEK
 
Diabetes epidemiology person, place, time graph
Diabetes epidemiology person, place, time graphDiabetes epidemiology person, place, time graph
Diabetes epidemiology person, place, time graph
ABHISHEK
 
Botulism I.S.M CENTRAL CAMPUS
Botulism I.S.M CENTRAL CAMPUSBotulism I.S.M CENTRAL CAMPUS
Botulism I.S.M CENTRAL CAMPUS
ABHISHEK
 
Helminthi I.S.M CENTRAL CAMPUS
Helminthi I.S.M CENTRAL CAMPUSHelminthi I.S.M CENTRAL CAMPUS
Helminthi I.S.M CENTRAL CAMPUS
ABHISHEK
 
Hepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUSHepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUS
ABHISHEK
 
Human immuno defeciency I.S.M CENTRAL CAMPUS
Human immuno defeciency  I.S.M CENTRAL CAMPUSHuman immuno defeciency  I.S.M CENTRAL CAMPUS
Human immuno defeciency I.S.M CENTRAL CAMPUS
ABHISHEK
 
Salmonellosis I.S.M CENTRAL CAMPUS
Salmonellosis I.S.M CENTRAL CAMPUSSalmonellosis I.S.M CENTRAL CAMPUS
Salmonellosis I.S.M CENTRAL CAMPUS
ABHISHEK
 

More from ABHISHEK (20)

Cells of the immune system
Cells of the immune systemCells of the immune system
Cells of the immune system
 
First line of defense ( barrier mechanisms)
First line of defense ( barrier mechanisms)First line of defense ( barrier mechanisms)
First line of defense ( barrier mechanisms)
 
Second line of defense
Second line of defenseSecond line of defense
Second line of defense
 
Vaccination
Vaccination Vaccination
Vaccination
 
Tuberculosis. epidemiology person, place, time graph
Tuberculosis. epidemiology person, place, time graphTuberculosis. epidemiology person, place, time graph
Tuberculosis. epidemiology person, place, time graph
 
Trauma epidemiology person, place, time graph
Trauma epidemiology person, place, time graphTrauma epidemiology person, place, time graph
Trauma epidemiology person, place, time graph
 
Stroke epidemiology person, place, time graph
Stroke epidemiology person, place, time graphStroke epidemiology person, place, time graph
Stroke epidemiology person, place, time graph
 
Sexually transmitted diseases (st ds) epidemiology person, place, time graph
Sexually transmitted diseases (st ds) epidemiology person, place, time graphSexually transmitted diseases (st ds) epidemiology person, place, time graph
Sexually transmitted diseases (st ds) epidemiology person, place, time graph
 
Pneumonia.epidemiology person, place, time graph
Pneumonia.epidemiology  person, place, time graphPneumonia.epidemiology  person, place, time graph
Pneumonia.epidemiology person, place, time graph
 
Malaria disease epidemiology person, place, time graph
Malaria disease epidemiology person, place, time graphMalaria disease epidemiology person, place, time graph
Malaria disease epidemiology person, place, time graph
 
Hypertension.epidemiology person, place, time graph
Hypertension.epidemiology person, place, time graphHypertension.epidemiology person, place, time graph
Hypertension.epidemiology person, place, time graph
 
Hiv disease epidemiology person, place, time graph
Hiv disease epidemiology person, place, time graphHiv disease epidemiology person, place, time graph
Hiv disease epidemiology person, place, time graph
 
Hepatitis epidemiology person, place, time graph
Hepatitis epidemiology person, place, time graphHepatitis epidemiology person, place, time graph
Hepatitis epidemiology person, place, time graph
 
Hepatitis – b ,epidemiology person, place, time graph
Hepatitis – b ,epidemiology person, place, time graphHepatitis – b ,epidemiology person, place, time graph
Hepatitis – b ,epidemiology person, place, time graph
 
Diabetes epidemiology person, place, time graph
Diabetes epidemiology person, place, time graphDiabetes epidemiology person, place, time graph
Diabetes epidemiology person, place, time graph
 
Botulism I.S.M CENTRAL CAMPUS
Botulism I.S.M CENTRAL CAMPUSBotulism I.S.M CENTRAL CAMPUS
Botulism I.S.M CENTRAL CAMPUS
 
Helminthi I.S.M CENTRAL CAMPUS
Helminthi I.S.M CENTRAL CAMPUSHelminthi I.S.M CENTRAL CAMPUS
Helminthi I.S.M CENTRAL CAMPUS
 
Hepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUSHepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUS
 
Human immuno defeciency I.S.M CENTRAL CAMPUS
Human immuno defeciency  I.S.M CENTRAL CAMPUSHuman immuno defeciency  I.S.M CENTRAL CAMPUS
Human immuno defeciency I.S.M CENTRAL CAMPUS
 
Salmonellosis I.S.M CENTRAL CAMPUS
Salmonellosis I.S.M CENTRAL CAMPUSSalmonellosis I.S.M CENTRAL CAMPUS
Salmonellosis I.S.M CENTRAL CAMPUS
 

Recently uploaded

Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
EduSkills OECD
 

Recently uploaded (20)

Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 

Covid 19 epidemiology

  • 2. COVID-19 What Is It? • Virus • Highly contagious • 3.5 times more deadly than the seasonal flu virus • Has already developed numerous variants throughout the world, which allow it to spread quicker than the original sars-cov-2 virus (Covid-19). Currently, not all variants have arrived in Canada and not all variants are listed below. • B.1.1.7 UK variant • B.1.351 South African variant • B.1.525 Nigerian variant • Cal.20C Californian variant • P.1 Brazilian variant
  • 3. Why is This so concerning? • With the variants spreading quicker; • It can put a strain on the healthcare resources (Covid-19 test sites, doctor’s offices, hospitals, labs) • It can lead to more hospitalizations • Potentially lead to more deaths • Existing health issues continue to compound, as surgeries would be cancelled and people will continue to avoid obtaining healthcare for routine preventative measures • It can put a strain on community resources (ex: taxi services and ambulance services take longer for turn around due to disinfectant processes, increased costs)
  • 4. How Does it Spread? • Through respiratory droplets • Close prolonged contact (defined as 15 minutes within a 24 timeframe) • Touching an infected area and then touching your eyes, nose or mouth • **It can survive on some surfaces outside the human body for up to 7 • days, but specifically; • Up to 3 hours as an aerosol • Up to 72 hours on plastic and stainless steel • Up to 4 hours on copper • Up to 24 hours on cardboard • 5 days on glass • 4 days on wood
  • 5. So, What Happens When You Get EXPOSED? • The virus gets in your body through your eyes, nose, or mouth • It attaches to the ACE2 receptors in the body, which is a protein that lines our organs (lungs, heart, blood vessels, kidneys, liver, GI tract) • Once it attaches to these proteins, it causes inflammation • This can overwhelm your immune system • Under certain conditions (increased risk factors discussed later), there is an increased risk of experiencing severe symptoms of the COVID-19, or even death
  • 6. Different Categories of Infection Once you are infected you are either: Asymptomatic (no symptoms for the duration) Pre-symptomatic (Currently exhibiting no symptoms but will eventually develop symptoms) Symptomatic (Currently exhibiting symptoms) The World Health Organization (WHO) believes that once you are infected, you have the potential to infect others, regardless of the degree of symptoms you are exhibiting. In fact, the WHO also believes that you are more likely to infect others around the time you are experiencing the onset of symptoms
  • 7. COVID-19 Symptoms • Watch for symptoms. • Symptoms can vary from person to person and in different age groups. • Symptoms may take up to 14 days to appear after exposure to COVID- 19. • The severity of COVID-19 symptoms can range from mild to severe, and in some cases, can lead to death. • Current information suggests most people don't experience severe illness or need to be hospitalized.
  • 8. EPIDEMIOLOGY • Since the initial report from China, the disease spread rapidly, and the number of cases increased exponentially. • On January 11, the first case was reported outside mainland China in Thailand, 7 and within months, the disease spread to all the continents except Antarctica. India reported its first case of COVID-19 on January 30, 2020. • This rose to three cases by February 3, 2020. No further cases were reported in February 2020. • However, by mid-March, the number of infected cases started to increase, and many cases were reported from all over India. • The first COVID-19 related death in India was reported on March 12, 2020. By the second week of April, the disease spread to all states in India except Sikkim. • At the time of writing this manuscript, there have been 2,170,265 cases and 135,163 deaths globally and 15,712 cases and 507 deaths in India.
  • 10. PLACE
  • 11. PLACE
  • 12. PLACE
  • 13. TIME
  • 14. COMMON SYMPTOMS Sore throat Cough (new or worsening) Shortness of breath Fever (chills, sweats) Headache
  • 15. YOU should get tested For COVID-19 • If you have symptoms of Covid-19 • If Public Health determines you are a close or moderate contact of a confirmed case of Covid-19 • If you were at a potential exposure site (see http://www.nshealth.ca/covid- exposures?title=&field_covid_exposure_zone_value=All&order=changed&sort=d esc for updated list and directions) • If you have travelled and arrived in Canada recently • If you don’t have symptoms, it is recommended that you get routine testing to ensure you are not an asymptomatic carrier of the virus • If you are experiencing any other symptoms that concern you • **If you are asked to isolate by 811, please inform your immediate supervisor and depending on the severity of your symptoms, discuss work options at that time
  • 16. Recovery • Most people with COVID-19 recover or feel better within two weeks. • Severe cases can take longer than 6 weeks and may or may not cause permanent damage to your organs. • There is currently insufficient research, but some individuals are reporting lingering symptoms after COVID- 19 infection (called long-haulers).
  • 17. PRIMARY PREVENTION • No compromise can be made for adherence to the main pillars of primary prevention including physical distancing, wearing a mask, keeping rooms well ventilated, avoiding crowds, cleaning the hands, and coughing into a bent elbow or tissue.
  • 18. secondary prevention • The secondary prevention measures of Coronavirus disease 2019 (COVID- 19)encompasses measures to make sure that an infected individual does not transfer the disease to others. • Infection Control : WHO recommends home care for patients with suspected COVID- 19 who present with mild symptoms. • It is highly recommended for people with suspected or affirmed COVID-19 (including those anticipating test results) should remain at home and attempt to isolate themselves from other members and animals in the family unit. • World Health Organization (WHO) has recommended wearing a medical mask if family members are in the same room with the COVID-19 patient to prevent the spread of the virus. Whereas, according to the United States Centers for Disease Control and Prevention (CDC), a cloth face Cover can be acceptable for caregivers at home and has considered the use of a medical mask for healthcare workers. • It is highly recommended for COVID-19.patients to use a separate bedroom and bathroom to prevent the spread of infection to family members. To avoid sharing rooms and if sharing space in a home is unavoidable, keeping a six feet (two meters) distance is extremely emphasized.
  • 19. secondary prevention Cont. • Care providers should perform hand hygiene after any form of contact with patients or their immediate environment. In a process of providing care to the patient, the caregiver should wear gloves while touching the patient's blood, stool, or body fluids, such as saliva, sputum, nasal mucus, vomit, and urine. • Certain things should not be shared with COVID-19 patients such as dishes, drinking glasses, cups, eating utensils, towels, bedding, and thermometers. After theCOVID-19 patients use these things, they should be properly disinfected. • COVID-19 patients who require nebulizer treatment and patients with sleep apnea who use continuous positive airway pressure (CPAP) machine should avoid using them in shared spaces where there is a risk of aerosol transmission to family members. • Symptomatic Treatment:• Symptomatic treatment of mild COVID-19 includes antipyretics and analgesics for fever, myalgias, and headaches.• Lying on a prone position has shown a symptomatic . improvement for patients with cough or dyspnea. • Anti-Viral Therapy for COVID-19:
  • 20. Tertiary prevention • Tertiary prevention strategies seek to treat and rehabilitate those with the clinical disease, toward reducing sequelae or complications and improving quality of life within a holistic or biopsychosocial framework.
  • 21. CREDITS: This presentation template was created by Slidesgo, including icons by Flaticon, and infographics & images by Freepik Thanks! Do you have any questions?